androgen receptor inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for androgen receptor inhibitor, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]